Top 10 Bestseller Diabetes Drugs in 2024 The global diabetes market in 2024 continues to be driven by innovation in GLP-1 therapies and next generation insulin formulations led by pharmaceutical giants like Novo Nordisk, Eli Lilly, Boehringer Ingelheim, AstraZeneca, and Sanofi
The resulting reduction in unsaturated fatty acid levels limits lipid peroxidation, thereby preserving NE structure
simulated iron overload during the progression of Parkinsons disease, revealing that ferroptosis occurred first in the low-concentration iron treatment group, followed by apoptosis with increased occurred after the increase in iron dose
IMA, the countrys largest organisation of modern medicine practitioners, is planning to seek a formal mandate restricting prescriptions of GLP-1 drugs to certified endocrinologists/diabetologists or MD general medicine practitioners to curb indiscriminate use and safeguard patient safety as access expands, Anilkumar J Nayak, national president, IMA, said in an exclusive interaction
